Is combined androgen and gonadotropin therapy a viable harm reduction strategy for men using high-dose exogenous androgens who are interested in family building?
Evan J. Panken M.D. , Joshua A. Halpern M.D., M.S.
{"title":"Is combined androgen and gonadotropin therapy a viable harm reduction strategy for men using high-dose exogenous androgens who are interested in family building?","authors":"Evan J. Panken M.D. , Joshua A. Halpern M.D., M.S.","doi":"10.1016/j.xfre.2025.03.010","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":34409,"journal":{"name":"FS Reports","volume":"6 2","pages":"Pages 127-128"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FS Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666334125000595","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}